Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline ...

The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...

Net Sales at Rs 949.42 crore in December 2024 up 17.9% from Rs. 805.26 crore in December 2023. Quarterly Net Profit at Rs.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues.View on euronews ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Manchester-based HIV charity George House Trust has won a GSK Impact Award – one of the nation’s top healthcare charity ...

Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the BSE.